Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pancreatic Adenocarcinoma × Irinotecan × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 66 Colonic Neoplasms 28 Rectal Neoplasms 27 Neoplasm Metastasis 14 Stomach Neoplasms 10 Pancreatic Neoplasms 9 Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Esophageal Neoplasms 6 Small Cell Lung Carcinoma 5 Rhabdomyosarcoma 4 Intestinal Neoplasms 4 Gastrointestinal Neoplasms 4 Digestive System Neoplasms 4 Uterine Cervical Neoplasms 3 Sarcoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Cholangiocarcinoma 3 Rectal Diseases 2 Neoplasms by Histologic Type 2 Intestinal Diseases 2 Hepatoblastoma 2 Gastrointestinal Diseases 2 Digestive System Diseases 2 Colorectal Cancer Metastatic 2 Colorectal Adenocarcinoma 2 Colonic Diseases 2 Carcinoma 2 Adenocarcinoma Of Esophagus 2 Stage I Mixed Cell Type Kidney Wilms Tumor 1

Interventions

Gemcitabine 2 Taxes 1 Radiotherapy, Intensity-Modulated 1 Irinotecan 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06250972 2025-08-07

PTCA199-11

Fudan University

Phase 3 Recruiting

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡